The health secretary says he will balance the arguments for and against mass testing ahead of a final decision due in March.

The recent FDA approval of the IsoPSA blood test may represent a notable advancement in prostate cancer screening and diagnosis. Developed by Cleveland Diagnostics, the in vitro diagnostic instrument ...

PSA stands for prostate-specific antigen, a substance naturally produced in prostate tissue. A small amount of PSA regularly sneaks into the bloodstream, and low blood concentration is considered ...

We have made important advancements in treatment, but are still being overwhelmed by the number of late-stage cases ...

Everything you need to know about the decision on who should be screened for prostate cancer ...

Canadian research suggests recommendations against screening for prostate cancer has led to a rise in the rates of stage 4 ...

Atlanta Falcons Legends join Emory Healthcare to raise awareness for prostate and lung cancer screening. Early detection can ...

A new 40-year study (1984-2023) of about a half-million prostate cancer cases – including 150,000 prostate cancer deaths – by the University of Ottawa, in conjunction with Stats Can, shows an alarming ...

It recommends that only men with a confirmed genetic risk of prostate cancer should be screened for the disease.

Targeted prostate cancer screening is helping identify men with early cases of the disease, says a group of Norwich health ...

Rather, the UK National Screening Committee (NSC) has recommended a targeted approach, only for men with a confirmed BRCA1 or ...